About BIOMETRY
BIOMETRY is a company based in Boston (United States) founded in 2013. BIOMETRY has raised $7.16 million across 2 funding rounds from investors including CareSource, Dexcom Ventures and Elevate Ventures. BIOMETRY offers products and services including FeNO Sensor, myBiometry App, and Prediction Engine. BIOMETRY operates in a competitive market with competitors including Aluna, Tueo Health, AioCare, alveofit and AsthmaTuner, among others.
- Headquarter Boston, United States
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
- Legal Name Biometry Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.16 M (USD)
in 2 rounds
-
Latest Funding Round
$2.16 M (USD), Seed
Dec 05, 2025
-
Investors
CareSource
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BIOMETRY
BIOMETRY offers a comprehensive portfolio of products and services, including FeNO Sensor, myBiometry App, and Prediction Engine.
Measures airway inflammation to predict asthma risks and triggers.
Aggregates data for personalized asthma risk predictions and insights.
Builds models from risk factors to forecast asthma attacks.
Funding Insights of BIOMETRY
BIOMETRY has successfully raised a total of $7.16M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.16 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $2.2M
-
First Round
First Round
(16 Aug 2024)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Seed - BIOMETRY | Valuation |
investors |
|
| Aug, 2024 | Amount | Seed - BIOMETRY | Valuation | Dexcom Ventures |
Investors in BIOMETRY
BIOMETRY has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include CareSource, Dexcom Ventures and Elevate Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Transformative health technology investments are made by Dexcom Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in diverse sectors by the firm.
|
Founded Year | Domain | Location | |
|
Healthcare-focused insurance brokerage services are provided in the United States.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BIOMETRY
Financial Statements - BIOMETRY
Biometry Comparisons
Competitors of BIOMETRY
BIOMETRY operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aluna, Tueo Health, AioCare, alveofit and AsthmaTuner, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Smart devices and apps for children's asthma tracking are provided.
|
|
| domain | founded_year | HQ Location |
In-home sensors monitor asthma in children via non-contact devices.
|
|
| domain | founded_year | HQ Location |
Developer of cloud-based SaaS solutions for care coordination and remote patient monitoring
|
|
| domain | founded_year | HQ Location |
Handheld digital spirometers are provided to monitor lung function.
|
|
| domain | founded_year | HQ Location |
Digital health platform for tracking lung symptoms and supporting providers.
|
|
| domain | founded_year | HQ Location |
Asthma monitoring device using sound for inhaler measurement is provided.
|
Frequently Asked Questions about BIOMETRY
BIOMETRY was founded in 2013 and raised its 1st funding round 11 years after it was founded.
BIOMETRY is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
BIOMETRY is a funded company, having raised a total of $7.16M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Aug 16, 2024.
A predictive analytics platform for managing medication adherence in patients was developed by Biometry, founded in 2013 and based in Boston, United States. Operations focus on the health technology sector, where a sensor-based breathalyzer device is utilized to measure FeNo levels as a biomarker for airway inflammation in asthma monitoring. Insights into patient health adherence and asthma status are delivered to physicians based on inhalation data.
BIOMETRY's top competitors include Aluna, AioCare and Tueo Health.
BIOMETRY offers FeNO Sensor, myBiometry App, and Prediction Engine.
BIOMETRY has 3 investors. Key investors include CareSource, Dexcom Ventures, and Elevate Ventures.